Requires health care professionals to prescribe opioid antagonists when prescribing an opioid and discuss the dangers of opioid addiction with such patient in a manner consistent with regulations promulgated by the commissioner of health.
Impact
The implementation of S07508 is expected to have a significant impact on state laws related to public health, specifically in the management of opioid prescriptions. By enforcing the requirement to prescribe an opioid antagonist, the bill could facilitate a proactive approach to mitigate the risks associated with opioid use. This legislative change may influence the way healthcare professionals engage with patients about the use of opioids and the potential need for emergency interventions to counteract overdoses.
Summary
Bill S07508 aims to enhance public health measures surrounding opioid prescriptions in the state of New York. It mandates that healthcare professionals must prescribe an opioid antagonist when they prescribe opioids to patients. This requirement is intended to reduce the risk of opioid overdose by providing a preventive measure alongside the prescribed opioids. The bill also obliges healthcare providers to discuss the dangers of opioid addiction with patients, ensuring they are informed about the risks associated with the medications they are receiving.
Contention
While many support the intent behind S07508, there may be contention regarding its implementation and the responsibilities it places on healthcare professionals. Some may argue that requiring the prescription of opioid antagonists could create additional burdens for doctors, complicating the prescribing process. Others may raise concerns about the adequacy of training and resources available to healthcare providers to effectively counsel patients on opioid addiction and ensure proper usage of prescribed antagonists.
Same As
Requires health care professionals to prescribe opioid antagonists when prescribing an opioid and discuss the dangers of opioid addiction with such patient in a manner consistent with regulations promulgated by the commissioner of health.
Requires health care professionals to prescribe opioid antagonists when prescribing an opioid and discuss the dangers of opioid addiction with such patient in a manner consistent with regulations promulgated by the commissioner of health.
Authorizes high schools to include opioid overdose prevention and non-intravenous opioid antagonist administration as optional part of required health education courses; authorizes certain students to administer non-intravenous opioid antagonists.
Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.
Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.
Requires school districts, public libraries, BOCES, county vocational education and extension boards, charter schools, and non-public schools to provide and maintain on-site opioid antagonists; requires the department of health to provide such opioid antagonists to such entities upon request.
Requires school districts, public libraries, BOCES, county vocational education and extension boards, charter schools, and non-public schools to provide and maintain on-site opioid antagonists; requires the department of health to provide such opioid antagonists to such entities upon request.
Requires practitioners to provide counselling to patients about the potential addictive properties of opioids prior to prescribing such medications; requires pharmacists to provide counselling to patients about the potential addictive properties of opioids at the time a prescription for opioids is filled.